This week's biggest news is that an AI system tested thousands of drug combinations and found one that could preserve nearly all normal lung function in IPF — a result that gives real hope for future treatments.
FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50–60%.
This is a computer model result — not a prescription. Always talk to your doctor before changing anything.
This week our database grew to over 8,100 IPF studies. Most new papers this week came from broad medical research, but the steady build-up of knowledge across lung scarring (fibrosis means the lungs slowly stiffen like scar tissue) studies continues. Researchers are looking at many angles — from genetics to how cells communicate — to understand why IPF happens and how to stop it.
The AI tested drug combinations and the best result kept FVC (a measure of how much air your lungs can hold and push out) at 98.3% of normal. That is remarkably close to healthy lung function. The seven drugs in this combination each target a different part of the scarring process — think of them as seven different repair crews fixing the same damaged building from different angles at once.
One question to ask your lung doctor at your next visit: Are any clinical trials testing combination anti-fibrotic therapies currently open near me, and would I be a good fit?